0001384101-20-000089.txt : 20200609
0001384101-20-000089.hdr.sgml : 20200609
20200609163310
ACCESSION NUMBER: 0001384101-20-000089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200609
DATE AS OF CHANGE: 20200609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EPSTEIN ROBERT S
CENTRAL INDEX KEY: 0001252004
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 20952258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wf-form4_159173477205679.xml
FORM 4
X0306
4
2020-06-08
0
0001384101
VERACYTE, INC.
VCYT
0001252004
EPSTEIN ROBERT S
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
26.3
2020-06-08
4
A
0
10000
0
A
2030-06-07
Common Stock
10000.0
10000
D
The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company.
/s/ Keith Kennedy, as Attorney-in-fact
2020-06-09